Fine structural alterations in the lungs of iprindole-treated rats.
D000284:Administration, Oral; D000818:Animals; D001485:Basement Membrane / Q000648:ultrastructure; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D007211:Indoles / Q000633:toxicity*; D007275:Injections, Intravenous; D007488:Iprindole / Q000633:toxicity*; D008168:Lung / Q000033:anatomy & histology / Q000473:pathology / Q000648:ultrastructure*; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008854:Microscopy, Electron; D008928:Mitochondria / Q000648:ultrastructure; D009929:Organ Size; D011650:Pulmonary Alveoli / Q000473:pathology; D011654:Pulmonary Edema / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D013047:Specific Pathogen-Free Organisms; D013194:Staining and Labeling; D013911:Thorium Dioxide / Q000008:administration & dosage
D007211:Indoles; D007488:Iprindole; D013911:Thorium Dioxide